Literature DB >> 3108794

Antibiotic prophylaxis in high-risk head and neck surgery: one-day vs. five-day therapy.

J T Johnson, D E Schuller, F Silver, J L Gluckman, R K Newman, F W Shagets, N L Snyderman, B Leipzig, R L Wagner.   

Abstract

Patients who undergo major contaminated surgery of the head and neck benefit from perioperative antibiotic prophylaxis. This study was developed to determine if 5 days of antibiotic administration would be more effective than 1 day. A multi-institutional prospective randomized double-blind study was designed. Patients who were identified as requiring pedicled flap reconstruction were potential candidates for the study. Later, patients were randomly assigned to receive cefoperazone sodium for either 24 hours or 120 hours. In each case, the drug was administered intravenously, beginning 1 to 2 hours preoperatively and continued for the prescribed period. One hundred nine patients were evaluable. Fifty-three patients were assigned to 1 day of perioperative prophylaxis. Wound infection developed in ten patients (18.9%). Fifty-six patients were assigned to 5 days of perioperative antibiotic prophylaxis. Wound infection developed in 14 (25%) of these patients (P greater than .05). These data suggest that no beneficial effect from administration of antibiotics for longer than 24 hours postoperatively can be achieved in patients who undergo myocutaneous flap reconstruction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3108794     DOI: 10.1177/019459988609500506

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

1.  Prevention and Treatment of Postsurgical Head and Neck Infections.

Authors:  Rebecca Fraioli; Jonas T. Johnson
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

2.  Advances in chemoprophylaxis for head and neck surgical wound infections.

Authors:  K T Robbins
Journal:  West J Med       Date:  1989-04

3.  Antibiotic use during major head and neck surgery.

Authors:  J T Johnson; V L Yu
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

4.  Evaluation of Prolonged vs Short Courses of Antibiotic Prophylaxis Following Ear, Nose, Throat, and Oral and Maxillofacial Surgery: A Systematic Review and Meta-analysis.

Authors:  Martinus C Oppelaar; Christian Zijtveld; Saskia Kuipers; Jaap Ten Oever; Jimmie Honings; Willem Weijs; Heiman F L Wertheim
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-07-01       Impact factor: 6.223

5.  Prognostic significance of wound infections following major head and neck cancer surgery: an open non-comparative prospective study.

Authors:  Nicolas Penel; Charles Fournier; Micheline Roussel-Delvallez; Danièle Lefebvre; Ahmed Kara; Yann Mallet; Jean-Charles Neu; Jean-Louis Lefebvre
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

6.  Comparative study of two cefazolin prophylactic protocols in oncologic surgery of the larynx: A randomized trial.

Authors:  Mohammad Taghy; Khorsandi Ashtiani; Mohammad Sadeghi; Babak Saedi; Gilda Givechi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-06-04

7.  Antibiotic Use after Free Tissue Reconstruction of Head and Neck Defects: Short Course vs. Long Course.

Authors:  Samir S Khariwala; Bin Le; Brendan H G Pierce; Rachel Isaksson Vogel; Jeffrey G Chipman
Journal:  Surg Infect (Larchmt)       Date:  2015-10-26       Impact factor: 2.150

8.  Antibiotic Prophylaxis Prescribing Practice in Head and Neck Tumor Resection and Free Flap Reconstruction.

Authors:  John Frederick Daly; Peter Francis Gearing; Nicholas Shi Jie Tang; Anand Ramakrishnan; Kasha Priya Singh
Journal:  Open Forum Infect Dis       Date:  2021-11-24       Impact factor: 3.835

9.  Antimicrobial Prophylaxis in Neonates and Children Undergoing Dental, Maxillo-Facial or Ear-Nose-Throat (ENT) Surgery: A RAND/UCLA Appropriateness Method Consensus Study.

Authors:  Erika Rigotti; Sonia Bianchini; Laura Nicoletti; Sara Monaco; Elena Carrara; Francesca Opri; Roberta Opri; Caterina Caminiti; Daniele Donà; Mario Giuffré; Alessandro Inserra; Laura Lancella; Alessandro Mugelli; Giorgio Piacentini; Nicola Principi; Simonetta Tesoro; Elisabetta Venturini; Annamaria Staiano; Alberto Villani; Enrico Sesenna; Claudio Vicini; Susanna Esposito
Journal:  Antibiotics (Basel)       Date:  2022-03-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.